Control group | Intervention group | P | |||
---|---|---|---|---|---|
Sex | %(n) | 0.75a | |||
Women | 68.7 (121) | 59.2(103) | |||
Men | 31.3(55) | 40.8(71) | |||
Overall | 100(176) | 100.0(174) | |||
Mean ± SD | |||||
Age (years) | 83.3 ± 6.9 | 80.8 ± 7.3 | 0.001b | ||
Weight (kg) | 65.5 ± 12.1 | 66.8 ± 12.0 | 0.335b | ||
Height (m) | 1.6 ± 0.1 | 1.6 ± 0.1 | 0.069b | ||
BMI (Kg/m2) | 26.1 ± 4.0 | 26.3 ± 3.8 | 0.721b | ||
SBP (mm Hg) | 130.7 ± 17.3 | 134.7 ± 18.7 | 0.060b | ||
DBP (mm Hg) | 71.5 ± 11.3 | 75.0 ± 12.3 | 0.012b | ||
Creatinine (mg/dl) | 1.1 ± 0.4 | 1.2 ± 0.8 | 0.052b | ||
Body surface (m2) | 1.7 ± 0.2 | 1.7 ± 0.2 | 0.162b | ||
GFR (ml/min/1.73 m2) | 61.7 ± 16.5 | 60.7 ± 17.0 | 0.572b | ||
CrCl (ml/min) | 45.0 ± 12.1 | 45. + ±13.0 | 0.525b | ||
CrCl-BS (ml/min/1.73 m2) | 46.3 ± 11.6 | 47.1 ± 12.6 | 0.550b | ||
Total number of drugs per patient | 7.3 ± 2.9 | 6.3 ± 3.2 | 0.003b | ||
Drugs with restriction in RI per patient | 4.0 ± 2.0 | 3.5 ± 2.1 | 0.069b | ||
Number of DRP per patient | 0.7 ± 1.0 | 0.5 ± 1.0 | 0.164b | ||
Prevalence of DI (%) | 17.5 ± 28.2 | 15.5 ± 29.1 | 0.514b | ||
Comorbidity %(n) | |||||
Hypertension | 72.2(127) | 69.5(121) | 0.639a | ||
T2DM | 23.9(42) | 11.5(20) | 0.003a | ||
Dyslipidemia | 39.8(70) | 37.4(65) | 0.662a | ||
Hyper/Hypo Thyroidism | 5.7(10) | 6.3(11) | 0.826a | ||
CVD | 30.7(54) | 23.6(41) | 0.150a | ||
CKD | 10.2(18) | 8.0(14) | 0.579a |